Experiment 955099

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPATENT DESCRIBED

Compounds isolated

BOSWELLIC ACID,BETA: ACETATE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationLEE,YW: FANG,QC: WANG,ZG: LI,D: COOK,CE:. (1990). PENTACYCLIC TRITERPENOID COMPOUNDS AS TOPOISOMERASE INHIBITORS OR CELL DIFFERENTIATION INDUCERS.. ()
Amount utilized
Compound isolated
DiseaseA MIXTURE OF ALPHA BOSWELLIC ACID ACETATE AND BETA BOSWELLIC ACID ACETATE WAS USED.
Dose amount100.0 MG
Number1
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE